Charles D. Nichols is an American pharmacologist who studies psychedelic drugs and inflammation.
[1][2][3] He also studied fruit flies for many years, including giving them psychedelics.
[1][4][2] Charles Nichols is a professor and researcher at Louisiana State University School of Medicine and the lead scientist of the psychedelic medicine pharmaceutical company Eleusis Therapeutics (since acquired by Beckley Psytech).
[2] The anti-inflammatory effects of psychedelics are of interest in the potential treatment of inflammatory diseases, such as asthma and neuroinflammation.
[2][4][9][7] Nichols has studied psychedelic microdosing in humans towards potential anti-inflammatory benefits.